© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Rein Therapeutics Inc. (RNTX) shows an Average True Range (ATR) of 0.11 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 650.85K, indicating liquidity. These fundamental metrics provide insight into RNTX's underlying financial health and market activity.
| ATR | 0.11 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 650.85K |
| Avg Vol (10 Days) | 358.81K |
Rein Therapeutics Inc. (RNTX) technical indicators as of July 22, 2026: the SMA 20 is 0.04%, SMA 50 at -3.83%, and SMA 200 at -14.28%. The RSI 14 value is 48.32, suggesting its current momentum. These technical analysis signals help assess RNTX's price trends and potential future movements.
| SMA 20 | 0.04% |
| SMA 50 | -3.83% |
| SMA 200 | -14.28% |
| RSI 14 | 48.32 |
Rein Therapeutics Inc. (RNTX) stock performance overview as of July 22, 2026: The 52-week high is $2.18 (currently -53.84% below), and the 52-week low is $0.83 (currently 17.65% above). Over the past year, RNTX's performance is -39.09%, compared to the S&P 500's 4.68% change.
| 52-Week High | 2.18 |
| 52-Week High Chg | -53.84% |
| 52-Week Low | 0.8299 |
| 52-Week Low Chg | +17.65% |
| S&P 500 52-Week Chg | 4.68% |
According to market data, Rein Therapeutics Inc. (RNTX) stock's recent performance metrics show that over the last month, RNTX is -7.69%, with a Year-to-Date (YTD) performance of 3.45%. Over the past year, the stock has seen a -39.09% change. These figures summarize RNTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.9598 | 1.05 | 2.1 | 2.1 | 2.18 | 2.1 |
| Low | 0.8299 | 0.8299 | 0.8299 | 0.8299 | 0.8299 | 0.8299 |
| Performance | +4.35% | -7.69% | -1.64% | -16.67% | -39.09% | +3.45% |
According to current financial data, RNTX stock's P/E (TTM) ratio is -0.48, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RNTX, including P/S (N/A), P/B (2.41), and P/FCF (-1.55), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RNTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.48 | -1.24 | 4857.74 | 32.59 |
| P/S (TTM) | N/A | 3.68 | 7.27 | 5.98 |
| P/B (TTM) | 2.41 | 0.13 | 5.59 | 5.29 |
| P/FCF (TTM) | -1.55 | -6.81 | -27.42 | 29.92 |